By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Alvine Pharmaceuticals, Inc. 

75 Shoreway Road
Suite B
San Carlos  California  94070   U.S.A.
Phone: 650-632-1645 Fax: 650-632-3396


Company News
Bay Area's Aimmune (AIMT) Taps Former Alvine Pharma-Sunesis (SNSS) Exec as New CMO 6/21/2016 6:47:35 AM
ImmunogenX Acquires The Assets Of Alvine Pharmaceuticals, Inc. 3/16/2016 9:34:23 AM
Alvine Pharmaceuticals, Inc. Doses First Patient in Phase 2b Trial for ALV003 in Celiac Disease 10/29/2013 10:04:04 AM
Alvine Pharmaceuticals, Inc. Lands $70 Million From AbbVie (ABBV) for Celiac Disease Drug 5/14/2013 10:09:01 AM
AbbVie (ABBV) and Alvine Pharmaceuticals, Inc. to Collaborate on Investigational Oral Therapy for Celiac Disease 5/14/2013 9:50:35 AM
Alvine Pharmaceuticals, Inc. Presents Celiac Disease Symptom Frequency and Severity Study Results at the 2012 American College of Gastroenterology Meeting 10/24/2012 9:18:31 AM
Alvine Pharmaceuticals, Inc. ALV003 Receives Fast Track Designation From the FDA for the Potential Treatment of Celiac Disease 9/5/2012 9:32:28 AM
Alvine Pharmaceuticals, Inc.'s ALV003 Named a Top 10 Inflammatory/Autoimmune Project to Watch by Windhover Information Inc. for a Rare Second Year 11/29/2011 10:07:27 AM
Alvine Pharmaceuticals, Inc. Presents Additional Efficacy Data From Phase 2a Trial of ALV003 in Celiac Disease Patients 10/24/2011 9:04:01 AM
Alvine Pharmaceuticals, Inc. Announces Positive Results From Phase 2a Trial of ALV003 in Celiac Disease Patients 10/11/2011 7:03:58 AM